Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency

Pediatric Hematology and Oncology

Volumn 26, Issue 2, 2009, Pages 98-103

  Tavil, Betul ^a   Sanal, Özden ^a   Turul, Tuba ^a   Yel, Leman ^a   Gurgey, Aytemiz ^a   Gumruk, Fatma ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Children; Immunodeficiency; Parvovirus B19; Pure red cell aplasia

Indexed keywords

COTRIMOXAZOLE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ITRACONAZOLE;

ARTICLE; B LYMPHOCYTE ACTIVATION; BONE MARROW BIOPSY; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG MEGADOSE; ERYTHEMA INFECTIOSUM; ERYTHROCYTE TRANSFUSION; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; MALE; PARVOVIRUS; POLYMERASE CHAIN REACTION; PURE RED CELL ANEMIA; SCHOOL CHILD; T LYMPHOCYTE; VIRUS GENOME; VIRUS NEUTRALIZATION; BONE MARROW; ISOLATION AND PURIFICATION; PATHOLOGY; VIROLOGY;

BONE MARROW; CHILD; ERYTHEMA INFECTIOSUM; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; PARVOVIRUS B19, HUMAN; RED-CELL APLASIA, PURE; T-LYMPHOCYTES;

EID: 67651213422     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010902754735     Document Type: Article

References (15)

1. Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004;350:586-597.
2. Kurtzman G, Cohen B, Meyers P, Amunullah A, Young NS. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukemia. Lancet. 1988;2:1159-1162.
3. Frickhofen N, Abkowitz J, Safford M, et al. Persistent parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Int Med. 1990;113:926-933.
4. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red cell aplasia of 10 years'duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med. 1989;321:519-523.
5. Choi SH, Chang SP, Won JC, et al. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection. Scand J Infect Dis. 2002;34:71-75.
6. Broliden K. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant. 2001;5:320-330.
7. Plentz A, Hahn J, Holler E, Jilg W, Modrow S. Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation. J Clin Virol. 2004;31:16-19.
8. Geetha D, Zachary JB, Baldado HM, Kronz JD, Kraus ES. Pure red cell aplasia caused by parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant. 2000;14:586-591.
9. Klar A, Halamish A, Shoseyov D, et al. Chronic human parvovirus B19 infection associated with interstitial lung disease. Isr Med Assoc J. 2002;4:825-826.
10. Sanphasitvong W, Poovorawan K, Boonsuk P, Assanasen T, Na Nakorn T, Poovorawan Y. Parvovirus b19 infection in HIV patient with pure red cell aplasia. Southeast Asian J Trop Med Public Health. 2005;36:1216-1220.
11. Chuhjo T, Nakao S, Matsuda T. Successful treatment of persistent erythroid aplasia caused by parvovirus B19 infection in a patient with common variable immunodeficiency with low-dose immunoglobulin. Am J Hematol. 1999;60:222-224.
12. Brown KE, Young NS, Liu JM. Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol. 1994;16:1-31.
13. Isobe Y, Sugimoto K, Shiraki Y, Nishitani M, Koike K, Oshimi K. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximabcombined chemotherapy. Am J Hematol. 2004;77:370-373.
14. Hayes-Lattin B, Seipel TJ, Gatter K, Heinrich MC, Maziarz RT. Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation. Am J Hematol. 2004;75:142-145.
15. Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvoviral infection in humans. J Infect Dis. 1985;152:257-265.